Chongqing Zhifei Bio Products Asset Resilience Ratio

Latest as of September 2023: -0.08%

Chongqing Zhifei Bio Products asset resilience ratio. Chongqing Zhifei Bio Products (300122) has an Asset Resilience Ratio of -0.08% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Chongqing Zhifei Bio Products liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥-41.38 Million

≈ $-6.05 Million USD Cash + Short-term Investments

Total Assets

CN¥49.27 Billion

≈ $7.21 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Chongqing Zhifei Bio Products (2014–2024)

Asset resilience ratio of Chongqing Zhifei Bio Products from 2014 to 2024. This chart shows how Chongqing Zhifei Bio Products's Asset Resilience Ratio has changed over time. Read Chongqing Zhifei Bio Products balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Chongqing Zhifei Bio Products's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Chongqing Zhifei Bio Products (300122) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-41.38 Million	-0.08%
Total Liquid Assets	CN¥-41.38 Million	-0.08%

Asset Resilience Insights

Limited Liquidity: Chongqing Zhifei Bio Products maintains only -0.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Chongqing Zhifei Bio Products Industry Peers by Asset Resilience Ratio

Compare Chongqing Zhifei Bio Products's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

Chongqing Zhifei Bio Products Asset Resilience Ratio by Year (2014–2024)

Chongqing Zhifei Bio Products asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for Chongqing Zhifei Bio Products.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.02%	CN¥11.53 Million ≈ $1.69 Million	CN¥49.91 Billion ≈ $7.30 Billion	+0.05pp
2022-12-31	-0.03%	CN¥-10.15 Million ≈ $-1.49 Million	CN¥38.00 Billion ≈ $5.56 Billion	+0.14pp
2021-12-31	-0.17%	CN¥-51.45 Million ≈ $-7.53 Million	CN¥30.05 Billion ≈ $4.40 Billion	+0.15pp
2020-12-31	-0.32%	CN¥-49.19 Million ≈ $-7.20 Million	CN¥15.22 Billion ≈ $2.23 Billion	-0.76pp
2019-12-31	0.44%	CN¥48.09 Million ≈ $7.04 Million	CN¥10.94 Billion ≈ $1.60 Billion	+0.92pp
2018-12-31	-0.49%	CN¥-33.04 Million ≈ $-4.84 Million	CN¥6.81 Billion ≈ $996.54 Million	-0.38pp
2017-12-31	-0.11%	CN¥-4.41 Million ≈ $-644.69K	CN¥4.11 Billion ≈ $600.82 Million	+0.14pp
2016-12-31	-0.25%	CN¥-6.76 Million ≈ $-989.50K	CN¥2.71 Billion ≈ $396.48 Million	-0.28pp
2015-12-31	0.03%	CN¥782.09K ≈ $114.44K	CN¥2.68 Billion ≈ $392.41 Million	+0.39pp
2014-12-31	-0.36%	CN¥-9.72 Million ≈ $-1.42 Million	CN¥2.71 Billion ≈ $397.21 Million	--

pp = percentage points

About Chongqing Zhifei Bio Products

SHE:300122 China Biotechnology

Market Cap

$4.73 Billion

CN¥32.29 Billion CNY

Market Cap Rank

#3578 Global

#437 in China

Share Price

CN¥13.49

Change (1 day)

+4.74%

52-Week Range

CN¥11.37 - CN¥21.77

All Time High

CN¥11976.62